Last reviewed · How we verify

NCT06702787: MEMENTO Regist

Mechanical Thrombectomy in the Middle East and North Africa: Interim Results from the MEMENTO Registry

ENROLLING BY INVITATION Last updated 25 November 2024
What this trial tests

trial in Stroke in 1,500 participants. Enrolling by invitation.

Timeline
11 March 2022
Primary endpoint
11 April 2025
11 September 2025

Quick facts

Lead sponsorMiddle East North Africa Stroke and Interventional Neurotherapies Organization
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment1,500
Start date11 March 2022
Primary completion11 April 2025
Estimated completion11 September 2025
Sites1 location across Egypt

Conditions studied

Sponsor

Middle East North Africa Stroke and Interventional Neurotherapies Organization

Who can join

Eligibility, any sex, with Stroke or Stroke Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The MEMENTO (MEchanical thrMobectomy NETwork for MENA TOgether) Registry is a multicenter, prospective observational study aiming to evaluate the effectiveness, safety, and cost-effectiveness of mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) due to large vessel occlusions (LVO) in the Middle East and North Africa (MENA) region. This interim analysis reports on the first 499 patients enrolled, assessing clinical outcomes, procedural details, and economic implications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Middle East North Africa Stroke and Interventional Neurotherapies Organization trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06702787.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing